1301 - 1350 of 8825 Results
Title
Year
-
OPENTitle: Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseasesJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 117Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jleuko/qiaf154Best OA location URL: https://academic.oup.com/jleukbio/advance-article-pdf/doi/10.1093/jleuko/qiaf154/65038951/qiaf154.pdfCitation Count: 0
-
RESTRICTEDTitle: Time for a New Image of Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 11Start Page: 1345End Page: 1345Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.2412Citation Count: 45
-
OPENTitle: Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”Journal Name: PeptidesPublisher: Elsevier BVVol: 131Issue #:Start Page: 170369End Page: 170369Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.peptides.2020.170369Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7448947Citation Count: 49
-
RESTRICTEDTitle: β-adrenoreceptors and the risk of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 247End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4Citation Count: 73
-
OPENTitle: Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative DiseasesJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 32Issue #: 12Start Page: 817End Page: 833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/ars.2019.7916Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7074890Citation Count: 52
-
OPENTitle: Vesicle trafficking and lipid metabolism in synucleinopathyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 4Start Page: 491End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02177-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7772270Citation Count: 43
-
OPENTitle: The multi‐faceted role of mitochondria in the pathology of Parkinson’s diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 156Issue #: 6Start Page: 715End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15154Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15154Citation Count: 66
-
OPENTitle: Probabilistic Modelling of Gait for Robust Passive Monitoring in Daily LifeJournal Name: IEEE Journal of Biomedical and Health InformaticsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 25Issue #: 6Start Page: 2293End Page: 2304Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jbhi.2020.3037857Best OA location URL: https://doi.org/10.1109/jbhi.2020.3037857Citation Count: 18
-
OPENTitle: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 214Issue #:Start Page: 102270End Page: 102270Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270Best OA location URL: https://doi.org/10.1016/j.pneurobio.2022.102270Citation Count: 217
-
RESTRICTEDTitle: Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Journal Name: Nature Reviews NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 2Start Page: 115End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41583-021-00542-9Citation Count: 198
-
OPENTitle: Multi-layer Trajectory Clustering: a Network Algorithm for Disease SubtypingJournal Name: Biomedical Physics & Engineering ExpressPublisher: IOP PublishingVol: 6Issue #: 6Start Page: 065003End Page: 065003Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/2057-1976/abad8fBest OA location URL: http://export.arxiv.org/pdf/2005.14472Citation Count: 6
-
OPENTitle: Unified deep learning approach for prediction of Parkinson's diseaseJournal Name: IET Image ProcessingPublisher: Institution of Engineering and Technology (IET)Vol: 14Issue #: 10Start Page: 1980End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1049/iet-ipr.2019.1526Best OA location URL: https://ietresearch.onlinelibrary.wiley.com/doi/pdfdirect/10.1049/iet-ipr.2019.1526Citation Count: 65
-
OPENTitle: Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study GroupJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 3Start Page: 322End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13158Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13158Citation Count: 13
-
OPENTitle: An Explainable Machine Learning Model for Early Detection of Parkinson's Disease using LIME on DaTSCAN ImageryJournal Name: Computers in Biology and MedicinePublisher: Elsevier BVVol: 126Issue #:Start Page: 104041End Page: 104041Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.compbiomed.2020.104041Best OA location URL: http://export.arxiv.org/pdf/2008.00238Citation Count: 193
- Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies2022OPENTitle: Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other SynucleinopathiesJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: s1Start Page: S149End Page: S163Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223245Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223245?id=journal-of-parkinsons-disease%2Fjpd223245Citation Count: 59
- Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?2023OPENTitle: Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?Journal Name: Current NeuropharmacologyPublisher: Bentham Science Publishers Ltd.Vol: 22Issue #: 10Start Page: 1583End Page: 1605Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1570159x21666230801140648Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11284713Citation Count: 1
-
OPENTitle: Infection and Risk of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 31End Page: 43Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202279Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202279?id=journal-of-parkinsons-disease%2Fjpd202279Citation Count: 125
-
OPENTitle: Neuroprotektive Therapien bei idiopathischen, genetischen und atypischen Parkinson-Syndromen mit α-Synuklein – PathologieJournal Name: Der NervenarztPublisher: Springer Science and Business Media LLCVol: 92Issue #: 12Start Page: 1249End Page: 1259Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00115-021-01220-yBest OA location URL: https://pub.dzne.de/record/163370Citation Count: 4
-
RESTRICTEDTitle: Human brain connectivity: Clinical applications for clinical neurophysiologyJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 131Issue #: 7Start Page: 1621End Page: 1651Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2020.03.031Citation Count: 116
- Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action2020OPENTitle: Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionJournal Name: European NeuropsychopharmacologyPublisher: Elsevier BVVol: 36Issue #:Start Page: 121End Page: 136Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.euroneuro.2020.05.006Best OA location URL: https://hdl.handle.net/11250/2729974Citation Count: 20
-
RESTRICTEDTitle: Stem-Cell Research of Parkinson Disease: Bibliometric Analysis of Research Productivity from 1999 to 2018Journal Name: World NeurosurgeryPublisher: Elsevier BVVol: 134Issue #:Start Page: e405End Page: e411Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.wneu.2019.10.087Citation Count: 13
-
OPENTitle: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 577End Page: 577Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00577Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00577/pdfCitation Count: 70
- Error in Figure2021OPENTitle: Error in FigureJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 86End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.16187Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2787448/jama_2021_cx_210045_1640892482.39958.pdfCitation Count: 0
-
OPENTitle: Analysis of EEG Data Using Complex Geometric StructurizationJournal Name: Neural ComputationPublisher: MIT Press - JournalsVol: 33Issue #: 7Start Page: 1942End Page: 1969Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1162/neco_a_01398Best OA location URL: https://arxiv.org/pdf/2102.09061Citation Count: 5
-
OPENTitle: Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and OpportunitiesJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page: 615461End Page: 615461Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.615461Best OA location URL: https://doi.org/10.3389/fcell.2020.615461Citation Count: 124
-
OPENTitle: Nucleic Acid–Based Therapeutics for Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 52
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019OPENTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7011644Citation Count: 43
-
OPENTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7234797Citation Count: 53
-
OPENTitle: The complex role of inflammation and gliotransmitters in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 176Issue #:Start Page: 105940End Page: 105940Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105940Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105940Citation Count: 38
-
RESTRICTEDTitle: Therapeutic approaches to cholinergic deficiency in Lewy body diseasesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 1Start Page: 41End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1676152Citation Count: 11
-
OPENTitle: Clinical Chronobiology: Circadian Rhythms in Health and DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 45Issue #: 03Start Page: 317End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1055/a-2538-3259Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12323393Citation Count: 2
-
OPENTitle: Targeting the proteostasis network in Huntington’s diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 49Issue #:Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2018.11.006Best OA location URL: https://doi.org/10.1016/j.arr.2018.11.006Citation Count: 78
-
OPENTitle: A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 11Start Page: 8129End Page: 8152Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14250Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14250Citation Count: 12
-
OPENTitle: Adapting the proteostasis capacity to sustain brain healthspanJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 6Start Page: 1545End Page: 1560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007Best OA location URL: http://www.cell.com/article/S0092867421001574/pdfCitation Count: 108
-
RESTRICTEDTitle: Volitional Control of Brain Motor Activity and Its Therapeutic PotentialJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 8Start Page: 1187End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.007Citation Count: 14
-
OPENTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 68
-
OPENTitle: Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 164Issue #:Start Page: 105625End Page: 105625Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105625Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105625Citation Count: 7
-
OPENTitle: Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and managementJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 547End Page: 555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000955Best OA location URL: https://hal.science/hal-03298526Citation Count: 19
-
OPENTitle: Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00302Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00302/pdfCitation Count: 56
-
RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 72
-
OPENTitle: The Global Brain Health Survey: Development of a Multi-Language Survey of Public Views on Brain HealthJournal Name: Frontiers in Public HealthPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpubh.2020.00387Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpubh.2020.00387/pdfCitation Count: 16
- Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases2019OPENTitle: Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseasesJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1315End Page: 1324Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27728Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27728Citation Count: 45
-
OPENTitle: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s DiseaseJournal Name: JACS AuPublisher: American Chemical Society (ACS)Vol: 2Issue #: 9Start Page: 2013End Page: 2022Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/jacsau.2c00300Best OA location URL: https://doi.org/10.1021/jacsau.2c00300Citation Count: 35
-
RESTRICTEDTitle: Mendel and urate: Acid test or random noise?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 53Issue #:Start Page: 1End Page: 3Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.005Citation Count: 3
-
OPENTitle: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 5Start Page: 514End Page: 514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9050514Best OA location URL: https://www.mdpi.com/2227-9059/9/5/514/pdf?version=1620466923Citation Count: 6
-
OPENTitle: How Vacations Affect Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 151End Page: 153Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13597Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13597Citation Count: 4
-
OPENTitle: Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral SclerosisJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2017.00216Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2017.00216/pdfCitation Count: 24
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 82
-
OPENTitle: Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 44Issue #: 7Start Page: 722End Page: 736Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/nan.12486Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.12486Citation Count: 50
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://n.neurology.org/content/neurology/73/20/1662.full.pdfCitation Count: 408